SS-31 Peptide Injection Dosage: What Research Actually Shows

There is no FDA-approved SS-31 peptide injection dosage for humans. The closest reference point comes from clinical trials of elamipretide, the pharmaceutical-grade form of SS-31, which used subcutaneous doses of 0.5 mg/kg per day or a flat 40 mg per day. Self-reported research protocols usually run lower, often 1 mg to 10 mg per day, and none of those numbers have been validated in healthy adults.

What SS-31 Is and Why Dosing Is Unsettled

SS-31, also known as elamipretide, is a synthetic tetrapeptide that binds to cardiolipin on the inner mitochondrial membrane. Researchers study it in mitochondrial myopathy, Barth syndrome, heart failure, and dry age-related macular degeneration.

The peptide has no approved human indication in the United States, so no manufacturer publishes a dosing label. Every number in circulation is either drawn from a clinical trial or repeated from a forum post, and those two sources carry very different weight.

Dosages Used in Published Clinical Trials

Investigators have dosed elamipretide either by body weight or with a fixed daily ceiling. The table below summarizes the regimens most often cited in peer-reviewed literature.

Protocol source	Dose	Route	Schedule	Evidence level
Barth syndrome trial (TAZPOWER)	0.5 mg/kg/day	Subcutaneous	Once daily	Supervised clinical trial
Mitochondrial myopathy and dry AMD trials	40 mg/day flat dose	Subcutaneous	Once daily	Supervised clinical trial
Online research forums	1–10 mg/day	Subcutaneous	Once daily, sometimes split	Anecdotal, unverified
Forum "loading" protocols	10–20 mg/day for 1–2 weeks	Subcutaneous	Once daily	No supporting safety data

These were monitored protocols with inclusion criteria, bloodwork, and adverse-event reporting. A trial dose is not a template for self-administration, and the 40 mg figure reflects a fixed ceiling used in specific patient populations rather than a general target.

Reconstitution Math for Common Vial Sizes

Research-grade SS-31 usually arrives as a lyophilized powder, so the injected amount depends entirely on how much diluent is added. A vial labeled ss-31 30mg can be mixed to several different concentrations, and each one changes the injection volume for the same dose.

Vial size	Bacteriostatic water added	Concentration	Volume for a 1 mg dose
10 mg	2 mL	5 mg/mL	0.20 mL
10 mg	5 mL	2 mg/mL	0.50 mL
30 mg	3 mL	10 mg/mL	0.10 mL
30 mg	6 mL	5 mg/mL	0.20 mL
50 mg	5 mL	10 mg/mL	0.10 mL

Small volume errors matter more as concentration rises. A 0.01 mL mistake at 10 mg/mL equals a 0.1 mg difference, which is why insulin syringes with fine unit markings are the usual measuring tool for these volumes.

Side Effects and Safety Considerations

In published trials, the most commonly reported ss 31 side effects were mild and localized, mainly injection-site reactions such as redness, swelling, or discomfort. Some participants also reported headache or dizziness, and serious events were uncommon during the relatively short study windows.

What remains unknown is the long-term picture. No trial has followed healthy adults using research-grade peptide for months or years, and impurity, sterility, and dosing errors in unregulated products add risks that controlled studies never had to account for.

Anyone with a chronic condition, taking prescription medication, pregnant, or breastfeeding should speak with a healthcare professional before injecting any research peptide.

Stacking and Related Research Peptides

Combination use is popular in online communities even though almost no human data supports it. Discussions about ss-31 and mots-c together typically pair a mitochondrial-targeted peptide with one associated with fatty-acid oxidation, and the rationale is theoretical rather than clinical.

People researching mitochondrial support sometimes compare it with epitalon dosage injection, although the two peptides are studied for different biological pathways and different endpoints. Any stacked protocol multiplies the number of unknowns, including how compounds interact and whether they compete for the same clearance routes.

Sourcing, Purity, and Legal Status

SS-31 sold online is labeled as a research chemical, not a drug. SS-31 is not FDA-approved for human use in the United States. Potency, sterility, and identity are therefore not guaranteed by any regulator, and a certificate of analysis should come from a third-party lab rather than the seller's own letterhead.

Anyone asking where to buy ss-31 peptide should treat purity documentation as the deciding factor, not price or marketing copy. Importing or possessing the peptide for personal injection also falls outside FDA approval and may conflict with state law.

Practical Takeaways

• No regulatory body has approved an SS-31 injection dosage for human use.
• Clinical trials used 0.5 mg/kg/day or a flat 40 mg/day subcutaneously in specific patient groups.
• Anecdotal protocols of 1–10 mg/day have no published safety or efficacy data behind them.
• Reconstitution volume determines the actual dose, so concentration math should be verified twice.
• Reported side effects in trials were mostly mild injection-site reactions, but long-term data do not exist.

COMMON QUESTIONS

Frequently Asked Questions

What is the typical SS-31 peptide injection dosage?

There is no approved dosage, because SS-31 is not FDA-approved for human use. Clinical trials of elamipretide used 0.5 mg/kg per day or a flat 40 mg per day given subcutaneously, while online protocols commonly cite 1–10 mg per day. The lower anecdotal numbers have no published safety or efficacy data behind them.

How do I reconstitute a 30 mg SS-31 vial?

Add bacteriostatic water slowly down the inside wall of the vial, then swirl instead of shaking. Three milliliters yields 10 mg/mL, while six milliliters yields 5 mg/mL, so a 1 mg dose measures 0.10 mL or 0.20 mL respectively. Use sterile technique and verify the math with a peptide calculator before drawing up.

Is SS-31 legal to buy and inject in the US?

SS-31 is sold as a research chemical rather than an approved drug, and vendors may not legally market it for human consumption. Buying it for personal injection falls outside FDA approval, and state laws vary. A licensed healthcare professional should be consulted before using any unapproved peptide.